Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter and Boehringer reported a Phase 3 failure.
Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...
Wegovy, Ozempic added to list of drugs where the federal government will try winning discounts from manufacturers.
40mon MSN
The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...
57m
SpaceX suspects a fire may have caused its Starship to break apart during liftoff and send trails of flaming debris near the Caribbean.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback